Overview

Insulin Therapy for Postreperfusion Hyperglycemia

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Glycemic control during liver transplantation is challenging especially after reperfusion of the liver graft. Insulin dose to treat postreperfusion hyperglycemia is retrospectively analyzed using historical data. The proposed dose then is prospectively applied to the patients to assess the adequacy of the insulin dose.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Insulin
Insulin, Globin Zinc